U.S. Physical Therapy Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Chris Reading

Algemeen directeur

US$3.4m

Totale compensatie

Percentage CEO-salaris	28.4%
Dienstverband CEO	20yrs
Eigendom CEO	0.6%
Management gemiddelde ambtstermijn	6.7yrs
Gemiddelde ambtstermijn bestuur	17.2yrs

Recente managementupdates

Recent updates

Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price

Nov 09

U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively

Aug 07

U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet

Jul 17

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't

Jun 04

There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings

May 21

U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44

May 11

Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)

May 05

A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)

Apr 21

Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?

Apr 07

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit

Mar 04

The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence

Dec 23

Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching

Dec 07

U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations

Oct 13

Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?

Aug 01

U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)

Jul 19

At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?

May 07

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price

Apr 16

U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet

Apr 01

Some Investors May Be Worried About U.S. Physical Therapy's (NYSE:USPH) Returns On Capital

Mar 04

U.S. Physical Therapy beats Q4 top and bottom line estimates; initiates FY23 outlook

Feb 23

U.S. Physical Therapy: Needs To Illustrate Economic Reality Over Accounting Profit

Feb 12

Is Now An Opportune Moment To Examine U.S. Physical Therapy, Inc. (NYSE:USPH)?

Jan 24

We Think U.S. Physical Therapy (NYSE:USPH) Can Stay On Top Of Its Debt

Dec 20

Here's Why We Think U.S. Physical Therapy (NYSE:USPH) Is Well Worth Watching

Dec 05

U.S. Physical Therapy: Not The Most Comfortable Prospect

Nov 09

Analyse CEO-vergoeding

Hoe is Chris Reading's beloning veranderd ten opzichte van U.S. Physical Therapy's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	US$14m
Jun 30 2024	n/a	n/a	US$16m
Mar 31 2024	n/a	n/a	US$18m
Dec 31 2023	US$3m	US$959k	US$18m
Sep 30 2023	n/a	n/a	US$24m
Jun 30 2023	n/a	n/a	US$26m
Mar 31 2023	n/a	n/a	US$28m
Dec 31 2022	US$2m	US$926k	US$29m
Sep 30 2022	n/a	n/a	US$39m
Jun 30 2022	n/a	n/a	US$38m
Mar 31 2022	n/a	n/a	US$37m
Dec 31 2021	US$4m	US$896k	US$31m
Sep 30 2021	n/a	n/a	US$31m
Jun 30 2021	n/a	n/a	US$30m
Mar 31 2021	n/a	n/a	US$32m
Dec 31 2020	US$3m	US$676k	US$32m
Sep 30 2020	n/a	n/a	US$30m
Jun 30 2020	n/a	n/a	US$31m
Mar 31 2020	n/a	n/a	US$29m
Dec 31 2019	US$3m	US$769k	US$31m
Sep 30 2019	n/a	n/a	US$30m
Jun 30 2019	n/a	n/a	US$23m
Mar 31 2019	n/a	n/a	US$18m
Dec 31 2018	US$3m	US$739k	US$17m
Sep 30 2018	n/a	n/a	US$18m
Jun 30 2018	n/a	n/a	US$22m
Mar 31 2018	n/a	n/a	US$21m
Dec 31 2017	US$2m	US$720k	US$22m

Compensatie versus markt: De totale vergoeding ($USD 3.37M ) Chris } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 5.50M ).

Compensatie versus inkomsten: De beloning van Chris is het afgelopen jaar met meer dan 20% gestegen, terwijl de winst van het bedrijf met meer dan 20% is gedaald.

CEO

Chris Reading (60 yo)

20yrs

Tenure

US$3,372,377

Compensatie

Mr. Christopher J. Reading, also known as Chris, has been the Chief Executive Officer of US Physical Therapy Inc. since November 1, 2004 and serves as its Chairman since May 21, 2024 and served as its Pres...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Christopher Reading	Chairman & CEO	20yrs	US$3.37m	0.63% $ 9.4m
Eric Williams	President & COO	3.3yrs	US$1.79m	0.098% $ 1.4m
Carey Hendrickson	Chief Financial Officer	4yrs	US$1.69m	0.14% $ 2.1m
Richard Binstein	Executive VP	13.8yrs	US$1.50m	0.085% $ 1.3m
Graham Reeve	Chief Operating Officer - West	6.7yrs	US$1.91m	0.13% $ 2.0m
Jake Martinez	Senior Vice President of Finance & Accounting	2.6yrs	geen gegevens	geen gegevens
Chadd Pence	Senior Vice President of Information Systems	no data	geen gegevens	geen gegevens
Jayne Pool	Senior VP & Chief Compliance Officer	no data	geen gegevens	geen gegevens
Jason Anderson	Vice President of Human Resources	no data	geen gegevens	geen gegevens
Jon Bates	VP & Corporate Controller	18yrs	geen gegevens	geen gegevens

6.7yrs

Gemiddelde duur

60yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van USPH is doorgewinterd en ervaren (gemiddelde ambtstermijn van 6.7 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Christopher Reading	Chairman & CEO	20yrs	US$3.37m	0.63% $ 9.4m
Nancy Ham	Independent Director	1.5yrs	US$215.92k	0.0074% $ 108.8k
Clayton Trier	Independent Director	19.8yrs	US$269.29k	0.043% $ 628.5k
Bernard Harris	Lead Independent Director	19.3yrs	US$264.29k	0.11% $ 1.6m
Kathleen Gilmartin	Independent Director	6.5yrs	US$256.54k	0.13% $ 1.8m
Reginald Swanson	Independent Director	17.2yrs	US$236.54k	0.13% $ 1.8m
Anne Motsenbocker	Independent Director	2.8yrs	US$239.04k	0.037% $ 550.2k

17.2yrs

Gemiddelde duur

67yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van USPH zijn ervaren en ervaren (gemiddelde ambtstermijn van 17.2 jaar).

U.S. Physical Therapy Beheer

Beheer criteriumcontroles 3/4

Belangrijke informatie

Recente managementupdates

President & COO recently sold US$192k worth of stock

Chairman & CEO notifies of intention to sell stock

Chairman & CEO recently sold US$212k worth of stock

Chief Operating Officer - East recently sold US$261k worth of stock

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Executive VP recently sold US$213k worth of stock

Recent updates

New minor risk - Insider selling

President & COO recently sold US$192k worth of stock

Shareholders Should Be Pleased With U.S. Physical Therapy, Inc.'s (NYSE:USPH) Price

Upcoming dividend of US$0.44 per share

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 6, 2024

U.S. Physical Therapy, Inc. to Report Q3, 2024 Results on Nov 05, 2024

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 13, 2024

U.S. Physical Therapy, Inc. announced delayed 10-Q filing

U.S. Physical Therapy (NYSE:USPH) Might Be Having Difficulty Using Its Capital Effectively

U.S. Physical Therapy, Inc. to Report Q2, 2024 Results on Aug 13, 2024

U.S. Physical Therapy (NYSE:USPH) Has A Rock Solid Balance Sheet

Now 20% undervalued after recent price drop

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Business Is Trailing The Industry But Its Shares Aren't

Chairman & CEO notifies of intention to sell stock

Chairman & CEO recently sold US$212k worth of stock

There May Be Reason For Hope In U.S. Physical Therapy's (NYSE:USPH) Disappointing Earnings

Chief Operating Officer - East recently sold US$261k worth of stock

U.S. Physical Therapy (NYSE:USPH) Is Due To Pay A Dividend Of $0.44

First quarter dividend of US$0.44 announced

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Returns On Capital Signal Tricky Times Ahead For U.S. Physical Therapy (NYSE:USPH)

A Look At The Fair Value Of U.S. Physical Therapy, Inc. (NYSE:USPH)

U.S. Physical Therapy, Inc., Annual General Meeting, May 21, 2024

Is Now The Time To Look At Buying U.S. Physical Therapy, Inc. (NYSE:USPH)?

Executive VP recently sold US$213k worth of stock

Executive VP notifies of intention to sell stock

Price target increased by 9.0% to US$119

Chief Operating Officer - West recently sold US$274k worth of stock

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Shareholders Might Be Looking For Exit

Upcoming dividend of US$0.44 per share

Fourth quarter dividend increased to US$0.44

New minor risk - Profit margin trend

Full year 2023 earnings: EPS misses analyst expectations

U.S. Physical Therapy, Inc. Increases Quarterly Dividend, Payable on April 5, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

U.S. Physical Therapy, Inc. to Report Q4, 2023 Results on Feb 28, 2024

The Returns On Capital At U.S. Physical Therapy (NYSE:USPH) Don't Inspire Confidence

Why U.S. Physical Therapy, Inc. (NYSE:USPH) Could Be Worth Watching

Now 20% undervalued after recent price drop

Price target decreased by 9.6% to US$110

Consensus EPS estimates fall by 10%

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on December 8, 2023

Price target decreased by 7.9% to US$118

Now 20% undervalued after recent price drop

U.S. Physical Therapy, Inc. to Report Q3, 2023 Results on Nov 07, 2023

U.S. Physical Therapy: Positioned For Market Dominance Amidst Attractive Valuations

Is U.S. Physical Therapy (NYSE:USPH) A Risky Investment?

U.S. Physical Therapy (NYSE:USPH) Could Be Struggling To Allocate Capital

Chief Operating Officer - West recently sold US$452k worth of stock

Should You Think About Buying U.S. Physical Therapy, Inc. (NYSE:USPH) Now?

Chief Operating Officer - West notifies of intention to sell stock

Second quarter 2023 earnings: EPS misses analyst expectations

U.S. Physical Therapy, Inc. Declares Quarterly Dividend, Payable on September 8, 2023

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired a 70% stake in U.S. Physical Therapy, Inc. (NYSE:USPH) for $2.1 million.

Are U.S. Physical Therapy, Inc. (NYSE:USPH) Investors Paying Above The Intrinsic Value?

U.S. Physical Therapy, Inc. to Report Q2, 2023 Results on Aug 08, 2023

U.S. Physical Therapy: Bolt-On Strategy Scaling Earnings Power (Rating Upgrade)

U.S. Physical Therapy, Inc. (NYSE:USPH) acquired 75% interest in Physical therapy practice with four clinics for $3.1 million

U.S. Physical Therapy, Inc. has completed a Follow-on Equity Offering in the amount of $150.00003 million.

Price target increased by 7.9% to US$119

U.S. Physical Therapy, Inc. Elects Nancy Ham to the Board of Directors

Upcoming dividend of US$0.43 per share at 1.6% yield

At US$114, Is U.S. Physical Therapy, Inc. (NYSE:USPH) Worth Looking At Closely?

First quarter 2023 earnings: EPS and revenues exceed analyst expectations

U.S. Physical Therapy Declares Quarterly Dividend, Payable on June 9, 2023

U.S. Physical Therapy, Inc.'s (NYSE:USPH) Intrinsic Value Is Potentially 25% Below Its Share Price

U.S. Physical Therapy (NYSE:USPH) Has A Pretty Healthy Balance Sheet

Independent Director recently sold US$463k worth of stock

Executive VP recently sold US$92k worth of stock